JP2008531695A5 - - Google Patents

Download PDF

Info

Publication number
JP2008531695A5
JP2008531695A5 JP2007558096A JP2007558096A JP2008531695A5 JP 2008531695 A5 JP2008531695 A5 JP 2008531695A5 JP 2007558096 A JP2007558096 A JP 2007558096A JP 2007558096 A JP2007558096 A JP 2007558096A JP 2008531695 A5 JP2008531695 A5 JP 2008531695A5
Authority
JP
Japan
Prior art keywords
blood
blood stem
stem cells
cells
tvemf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007558096A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008531695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/006817 external-priority patent/WO2006093858A2/en
Publication of JP2008531695A publication Critical patent/JP2008531695A/ja
Publication of JP2008531695A5 publication Critical patent/JP2008531695A5/ja
Pending legal-status Critical Current

Links

JP2007558096A 2005-02-28 2006-02-27 糖尿病の治療の方法及び組成物 Pending JP2008531695A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65755305P 2005-02-28 2005-02-28
PCT/US2006/006817 WO2006093858A2 (en) 2005-02-28 2006-02-27 Method and composition for treating diabetes

Publications (2)

Publication Number Publication Date
JP2008531695A JP2008531695A (ja) 2008-08-14
JP2008531695A5 true JP2008531695A5 (enExample) 2009-04-09

Family

ID=36941684

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007558096A Pending JP2008531695A (ja) 2005-02-28 2006-02-27 糖尿病の治療の方法及び組成物

Country Status (11)

Country Link
US (1) US20060193838A1 (enExample)
EP (1) EP1855535A4 (enExample)
JP (1) JP2008531695A (enExample)
KR (1) KR20070111533A (enExample)
CN (1) CN101188941A (enExample)
BR (1) BRPI0607882A2 (enExample)
CA (1) CA2599275A1 (enExample)
EA (1) EA200701826A1 (enExample)
IL (1) IL185555A0 (enExample)
MX (1) MX2007010531A (enExample)
WO (1) WO2006093858A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060193839A1 (en) * 2005-02-28 2006-08-31 Donnie Rudd Method of providing readily available cellular material derived from peripheral blood, and a composition thereof
CN101415816A (zh) * 2006-02-02 2009-04-22 雷格内泰克公司 表征生物活性化合物的方法
US20090081752A1 (en) * 2007-09-24 2009-03-26 Dennis Robert G Bioreactor, kit and method of using same
US8993231B2 (en) * 2008-03-18 2015-03-31 Marshall University Research Corporation Methods for stem cell production and therapy
JP6691048B2 (ja) 2013-10-24 2020-04-28 オスペダーレ サン ラファエレ エス.アール.エル 方法
US10202598B2 (en) * 2014-05-30 2019-02-12 Todd Frank Ovokaitys Methods and systems for generation, use, and delivery of activated stem cells
US9410143B1 (en) 2014-06-10 2016-08-09 Endonovo Therapeutics, Inc. Biological molecules produced by electromagnetically stimulating living mammalian cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192553A (en) * 1987-11-12 1993-03-09 Biocyte Corporation Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use
US5728581A (en) * 1995-06-07 1998-03-17 Systemix, Inc. Method of expanding hematopoietic stem cells, reagents and bioreactors for use therein
US6962698B1 (en) * 1998-02-17 2005-11-08 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
US6485963B1 (en) * 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002220712A1 (en) * 2000-11-29 2002-06-11 William Rader Stem cells, method for expansion in vitro and use thereof
AU2003277205A1 (en) * 2002-10-02 2004-04-23 New York University Adult bone marrow derived stem cells
DE10362002B4 (de) * 2003-06-23 2006-10-12 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Adulte pluripotente Stammzellen
US20060205071A1 (en) * 2003-07-17 2006-09-14 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
US20050084962A1 (en) * 2003-08-20 2005-04-21 Bruce Simon Methods of treatment using electromagnetic field stimulated stem cells
US20080057042A1 (en) * 2005-01-27 2008-03-06 Donnie Rudd Method of providing readily available cellular material derived from cord blood, and a composition thereof
US20080050348A1 (en) * 2006-02-27 2008-02-28 Donnie Rudd Method and composition for repairing heart tissue
US20080075700A1 (en) * 2006-02-27 2008-03-27 Wolf David A Method and composition for treating diabetes

Similar Documents

Publication Publication Date Title
US9387226B2 (en) Neural cell proliferation induced through the culture of neural cells with umbilical cord blood-derived mesenchymal stem cells
JP2009533059A5 (enExample)
US10092599B2 (en) Methods for enhancing hematopoietic stem/progenitor cell engraftment
JP2010527988A5 (enExample)
US20130028870A1 (en) Pluripotent stem cells and method of stimulating and extracting non-embryonic pluripotent stem cells from mammal blood and using reconstituted pluripotent stem cells to treat diseases including chronic obstructive pulmonary disease
Du et al. Primary microglia isolation from postnatal mouse brains
Wang et al. Human-induced pluripotent stem cell–derived neural stem cell exosomes improve blood–brain barrier function after intracerebral hemorrhage by activating astrocytes via PI3K/AKT/MCP-1 axis
CN111557951A (zh) 一种间充质干细胞治疗病毒性感染患者的新方法
JP2008531695A5 (enExample)
CN116355846B (zh) 一种质量稳定可控的扩增活化淋巴细胞的方法及其用于防治神经科疾病中的用途
US10159697B2 (en) Methods for enhancing hematopoietic stem/progenitor cell engraftment
KR100959995B1 (ko) 인간 제대혈 유래 간엽 줄기세포를 유효성분으로 포함하는,신경전구세포 또는 신경줄기세포의 신경세포로의 분화 및증식 유도용 조성물
US20220226390A1 (en) Clinical-grade autologous bronchial basal cell, deliverable formulation, and preparation process
CA2819130A1 (en) Compositions and methods for mobilizing stem cells
CN114432347B (zh) 产神经酸的微藻在制备治疗脊髓损伤的产品中的应用
JP2008531698A5 (enExample)
US20080206196A1 (en) Differentiation of cord blood into neural like cells, and method to treat neurological condition patients
CN102559591A (zh) 一种提取肺间充质干细胞的方法
Ren et al. Cells therapy for Parkinson’s disease—so close and so far away
CN107441128A (zh) 一种促进损伤神经再生和功能恢复的药物组合物及其应用和干细胞注射液及其制备方法
US20250127816A1 (en) Systems and methods for growing mitochondria and coating thereof
CN107243006B (zh) Amd3100在制备治疗和/或预防恶液质的药物中的应用
CN101054571A (zh) 一种胰岛细胞体外增殖方法
TWI652057B (zh) 白藜蘆醇之應用
CN1803193A (zh) 骨髓来源的间质干细胞用于制备治疗缺氧缺血性脑性瘫痪的制剂的用途